Inhibitorofcyclooxygenase(COX)-1.Blockstheproductionofprostaglandinsandthromboxanes.Exhibitsantiplateletandantithromboticactivities.Displaysanticancereffectsinsomesolidtumors.OneofthefirstdescribedNSAIDdrugs.
AspirinisalsoofferedaspartoftheTocriscreenPlusandTocriscreenLibraryofFDA-ApprovedCompounds.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
M.Wt | 180.16 |
Formula | C9H8O4 |
Storage | StoreatRT |
Purity | ≥99%(HPLC) |
CASNumber | 50-78-2 |
PubChemID | 2244 |
InChIKey | BSYNRYMUTXBXSQ-UHFFFAOYSA-N |
Smiles | CC(OC1=C(C(O)=O)C=CC=C1)=O |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 18.02 | 100 | |
water | 1.8 | 10 |
Thefollowingdataisbasedontheproductmolecularweight180.16.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 5.55mL | 27.75mL | 55.51mL |
5mM | 1.11mL | 5.55mL | 11.1mL |
10mM | 0.56mL | 2.78mL | 5.55mL |
50mM | 0.11mL | 0.56mL | 1.11mL |